THE INFLUENCE OF APROTININ ON REGIONAL ABSORPTION OF SOLUBLE HUMAN INSULIN

[1] ALBERTI KGM, 1973, LANCET, V2, P1299

[2] ABSORPTION KINETICS AND BIOLOGIC EFFECTS OF SUBCUTANEOUSLY INJECTED INSULIN PREPARATIONS [J]. DIABETES CARE, 1982, 5 (02) : 77 - 91

[3] THE EFFECT OF APROTININ ON THE ABSORPTION OF SUBCUTANEOUSLY INJECTED REGULAR INSULIN IN NORMAL SUBJECTS [J]. DIABETES, 1980, 29 (01) : 81 - 83

[4] BINDER C, 1969, ACTA PHARM TOX S2, V26, P1

[5] DANDONA P, 1985, DIABETES RES CLIN EX, V2, P213

[6] DETERMINATION OF TOTAL SERUM-INSULIN (IRI) IN INSULIN-TREATED DIABETIC PATIENTS [J]. DIABETOLOGIA, 1972, 8 (04) : 260 - &

[7] HILDEBRANDT P, 1983, DIABETOLOGIA, V23, P174

[8] KOLENDORF K, 1979, CLIN PHARMACOL THER, V25, P598

[9] LAURITZEN T, 1980, ACTA PAEDIATR SC S, V283, P81

[10] INFLUENCE OF APROTININ ON INSULIN ABSORPTION AND SUBCUTANEOUS BLOOD-FLOW IN TYPE-1 (INSULIN-DEPENDENT) DIABETES [J]. DIABETOLOGIA, 1985, 28 (09) : 645 - 648

[1] ALBERTI KGM, 1973, LANCET, V2, P1299

[2] ABSORPTION KINETICS AND BIOLOGIC EFFECTS OF SUBCUTANEOUSLY INJECTED INSULIN PREPARATIONS [J]. DIABETES CARE, 1982, 5 (02) : 77 - 91

[3] THE EFFECT OF APROTININ ON THE ABSORPTION OF SUBCUTANEOUSLY INJECTED REGULAR INSULIN IN NORMAL SUBJECTS [J]. DIABETES, 1980, 29 (01) : 81 - 83

[4] BINDER C, 1969, ACTA PHARM TOX S2, V26, P1

[5] DANDONA P, 1985, DIABETES RES CLIN EX, V2, P213

[6] DETERMINATION OF TOTAL SERUM-INSULIN (IRI) IN INSULIN-TREATED DIABETIC PATIENTS [J]. DIABETOLOGIA, 1972, 8 (04) : 260 - &

[7] HILDEBRANDT P, 1983, DIABETOLOGIA, V23, P174

[8] KOLENDORF K, 1979, CLIN PHARMACOL THER, V25, P598

[9] LAURITZEN T, 1980, ACTA PAEDIATR SC S, V283, P81

[10] INFLUENCE OF APROTININ ON INSULIN ABSORPTION AND SUBCUTANEOUS BLOOD-FLOW IN TYPE-1 (INSULIN-DEPENDENT) DIABETES [J]. DIABETOLOGIA, 1985, 28 (09) : 645 - 648